Mabtas T 100 mg Injection
$85.00
$66.30
Mabtas T 100 mg Injection is a targeted monoclonal antibody therapy designed to combat a range of conditions, primarily those affecting the immune system. This innovative treatment is especially effective for specific types of cancer, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia, offering hope to many patients. By selectively binding to cancerous cells, Mabtas T helps the immune system to recognize and destroy these abnormal cells more efficiently. It is important to be aware that this medication may cause potential side effects, including infusion reactions and infections, necessitating careful monitoring by healthcare professionals. Patients receiving Mabtas T should be informed about the signs of allergic reactions and should consult their physician if they experience any unusual symptoms. As a critical component of cancer therapy, Mabtas T provides a vital option for individuals seeking effective management of their condition. Always follow your healthcare provider’s instructions and ensure regular follow-ups to maximize the benefits of this treatment.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Mabtas t 100 mg injection is primarily used in the treatment of Non-Hodgkin lymphoma (NHL). This form of cancer affects the lymphatic system, and Mabtas t helps to target and eliminate malignant cells. By modulating the immune response, it aids in controlling the progression of the disease. Patients receiving this treatment may experience improved outcomes in their cancer management.
• Another significant use of Mabtas t 100 mg injection is in the management of rheumatoid arthritis. This autoimmune condition leads to joint inflammation and pain, and Mabtas t works by reducing the immune system's overactivity. As a result, patients may find relief from symptoms and improved joint function. This can enhance their quality of life and daily activities.
• Mabtas t 100 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia (CLL), a type of blood cancer characterized by the accumulation of abnormal lymphocytes. The injection assists in targeting these harmful cells, thereby slowing disease progression. Patients often receive this therapy as part of a comprehensive treatment plan. Its effectiveness can lead to better disease management.
• In addition, Mabtas t 100 mg injection is utilized in treating granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune disorders that cause inflammation of blood vessels, leading to organ damage. Mabtas t helps by modulating the immune response, thus reducing inflammation and preventing further complications. This can significantly improve patient outcomes and overall health.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Mabtas T 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Mabtas T 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Mabtas T 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Mabtas T 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Mabtas T 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Mabtas T 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Mabtas T 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Mabtas T 100 mg. Please consult your doctor.
• Kidney: Mabtas T 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Mabtas T 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Mabtas T 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Mabtas T 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Mabtas T 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.